GlassScriptPhysician profile
Brandon Lee Morris
NPI 1215373196
$26,104.12
in general payments reported to CMS, 2019-2025
19 companies · $395 in 2025
The $395 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21K · 2020: $1,904 · 2021: $1,391 · 2022: $151 · 2023: $975 · 2024: $593 · 2025: $395.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,003 · Food and Beverage: $959.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,003.25 |
| Food and Beverage | $959.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $20,000.00 | 2019 | |
| Stryker Corporation | $2,596.74 | 2019-2025 | Prostep, Blueprint Patient Specific Instrumentation, Gamma |
| Titan Surgical Group, LLC | $2,223.00 | 2020-2021 | |
| Intuitive Surgical, INC. | $392.13 | 2020 | |
| Depuy Synthes Sales INC. | $256.22 | 2019-2025 | Orthovisc, Monovisc, Peak |
| Zimmer Biomet Holdings, INC. | $210.09 | 2019-2023 | Persona |
| Smith+Nephew, INC. | $123.68 | 2024-2025 | Healicoil, Spatial Frame, Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Dunamis Medical, LLC | $82.02 | 2025 | |
| Djo, LLC | $43.27 | 2024 | Cmf |
| Vertex Pharmaceuticals Incorporated | $27.82 | 2025 | |
| Becton, Dickinson and Company | $26.23 | 2022 | |
| Solventum Corporation | $24.14 | 2025 | V.A.C.Ulta |
| Amgen INC. | $18.89 | 2023 | Evenity, Prolia |
| Melinta Therapeutics, LLC | $16.52 | 2023 | Orbactiv, Kimyrsa |
| Pacira Pharmaceuticals Incorporated | $16.15 | 2025 | Exparel |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $15.12 | 2025 | Durolane |
| Pacira Therapeutics, INC. | $13.93 | 2021 | |
| Baudax Bio INC. | $11.02 | 2020 | |
| Skeletal Dynamics INC | $7.15 | 2025 | Geminus, Implate, Align |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Morris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.